(Q45071429)

9 December 2017

0 references

A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA. (English)

1 reference

9 December 2017

L H Gold

1

1 reference

9 December 2017

C B Hubner

series ordinal

2

1 reference

9 December 2017

G F Koob

series ordinal

3

1 reference

9 December 2017

publication date

1 January 1989

1 reference

9 December 2017

number of pages

8

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

9 December 2017

volume

99

1 reference

9 December 2017

issue

1

1 reference

9 December 2017

page(s)

40-47

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00634450

9 December 2017

exact match

0 references

cites work

Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

1 reference

12 December 2020

The pharmacological and anatomical substrates of the amphetamine response in the rat

1 reference

12 December 2020

Lesions of Central Norepinephrine Terminals with 6-OH-Dopamine: Biochemistry and Fine Structure

1 reference

12 December 2020

Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain

1 reference

12 December 2020

Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain

1 reference

12 December 2020

Methylenedioxymethamphetamine: a potentially neurotoxic amphetamine analogue

1 reference

12 December 2020

Methysergide potentiates the hyperactivity produced by MDMA in rats

1 reference

12 December 2020

The relative importance of dopamine and norepinephrine in mediating locomotor activity

1 reference

12 December 2020

(+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats

1 reference

12 December 2020

Discriminative profile of MDMA.

1 reference

12 December 2020

The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

1 reference

12 December 2020

Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography

1 reference

12 December 2020

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain

1 reference

12 December 2020

Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways

1 reference

12 December 2020

Subjective effects of 3,4-methylenedioxymethamphetamine in recreational users.

1 reference

12 December 2020

New data intensify the agony over ecstasy

1 reference

12 December 2020

Can drugs be used to enhance the psychotherapeutic process?

1 reference

12 December 2020

'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA

1 reference

12 December 2020

Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamine and N-ethyl-3,4-methylenedioxyamphetamine in rats.

1 reference

12 December 2020

Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class.

1 reference

12 December 2020

Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats

1 reference

12 December 2020

Drug discrimination studies with MDMA and amphetamine

1 reference

12 December 2020

Designer drug confusion: a focus on MDMA

1 reference

12 December 2020

Effects of certain hallucinogenic amphetamine analogues on the release of [3H]serotonin from rat brain synaptosomes.

1 reference

12 December 2020

Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine

1 reference

12 December 2020

The threshold lowering effects of MDMA (ecstasy) on brain-stimulation reward

1 reference

12 December 2020

Differences in the stimulus properties of 3,4-methylenedioxyamphetamine and 3,4- methylenedioxymethamphetamine in animals trained to discriminate hallucinogens from saline.

1 reference

12 December 2020

Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus

1 reference

12 December 2020

The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-B-hydroxylase as a marker

1 reference

12 December 2020

Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum

1 reference

12 December 2020

Mechanisms of action of 6-hydroxydopamine

1 reference

12 December 2020

Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)

1 reference

12 December 2020

Amphetamine-, scopolamine- and caffeine-induced locomotor activity following 6-hydroxydopamine lesions of the mesolimbic dopamine system

1 reference

12 December 2020

Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon.

1 reference

12 December 2020

Anatomical analysis of the involvement of mesolimbocortical dopamine in the locomotor stimulant actions of d-amphetamine and apomorphine

1 reference

12 December 2020

The acute effects of methylenedioxymethamphetamine on dopamine release in the awake-behaving rat.

1 reference

12 December 2020

Regional concentrations of noradrenaline and dopamine in rat brain

1 reference

12 December 2020

Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites

1 reference

12 December 2020

Behavioral effects of xylamine-induced depletions of brain norepinephrine: interaction with amphetamine

1 reference

12 December 2020

Ascending catecholamine pathways and amphetamine-induced locomotor activity: Importance of dopamine and apparent non-involvement of norepinephrine

1 reference

12 December 2020

Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens.

1 reference

12 December 2020

Stimulus properties of 1-(3,4-methylenedioxyphenyl)-2-aminopropane (MDA) analogs

1 reference

12 December 2020

Partial protection by desmethylimipramine of the mesocortical dopamine neurones from the neurotoxic effect of 6-hydroxydopamine injected in ventral mesencephalic tegmentum. The role of noradrenergic innervation

1 reference

12 December 2020

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices

1 reference

12 December 2020

Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats

1 reference

12 December 2020

The relative importance of dopaminergic and noradrenergic neuronal systems for the stimulation of locomotor activity induced by amphetamine and other drugs

1 reference

12 December 2020

Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine

1 reference

12 December 2020

Non-dopaminergic fibres may regulate dopamine-sensitive adenylate cyclase in the prefrontal cortex and nucleus accumbens

1 reference

12 December 2020

Blockade of amphetamine but not opiate-induced locomotion following antagonism of dopamine function in the rat.

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites

1 reference

12 December 2020

In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain

1 reference

12 December 2020

Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis

1 reference

12 December 2020

An inhibitory role for brain serotonin-containing systems in the locomotor effects of d-amphetamine

1 reference

12 December 2020

Acute administration of methylenedioxymethamphetamine: comparison with the neurochemical effects of its N-desmethyl and N-ethyl analogs

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00634450

1 reference

Dimensions Publication ID

9 December 2017

1021068216

0 references

1 reference